Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients With Early-Stage Breast Cancer or Non-Hodgkin Lymphoma
PharmacoEconomics - United Kingdom
doi 10.1007/s40273-016-0474-0
Full Text
Open PDFAbstract
Available in full text
Date
December 7, 2016
Authors
Publisher
Springer Science and Business Media LLC